LMN-201 for Prevention of C. Difficile Infection Recurrence — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(16 sites)
United States
Kaiser Permanente, Escondido, California Bridgeport Hospital, Bridgeport, Connecticut Gastroenterology Center of Connecticut, Hamden, Connecticut GI PROS Research, Naples, Florida Metro Infectious Disease Consultants - Atlanta, Decatur, Georgia Snake River Research, Idaho Falls, Idaho Metro Infectious Disease Consultants, LLC, Burr Ridge, Illinois DM Clinical Research, Oak Lawn, Illinois Baptist Health Research, Lexington, Kentucky University of Minnesota, Minneapolis, Minnesota Mercury Street Medical, Butte, Montana Quality Clinical Research, Inc, Omaha, Nebraska Weill Cornell Medicine, New York, New York IMA Clinical Research, Mount Airy, North Carolina MD Anderson Cancer Center, Houston, Texas Clinical Alliance for Infectious Diseases - Infectious Diseases, LLC, Annandale, Virginia Age range
18 Years and older
Last updated February 2026